Clinical observation of ambroxol budesonide and terbutaline combinedly atomized inhalation for old patients with acute exacerbation of chronic obstructive pulmonary disease

VernacularTitle:老年慢性阻塞性肺疾病急性加重期的药物联合雾化吸入治疗
Author: Zhanxiang LIU ; Yanli LI ; Anmeng WEI ; Ce SHI ; Xiuli ZHANG ; Yanhong LIU
Publication Type:Journal Article
Keywords: Chronic obstructive pulmonary disease; Ambroxol; budesonide; Terbutaline; Atomized inhalation
From: Chinese Journal of Primary Medicine and Pharmacy 2009;16(7):1235-1236
CountryChina
Language:Chinese
Abstract: Objective To evaluate the clinical effect of ambroxol, budesonide and obstructive combinedly atomized inhalation on old patients with acute exacerbation of chronic obstructive pulmonary disease(COPD). Meth-ods 60 old patients with acute exacerbation of COPD were allocated into two groups in random, the control group(n =30) and the treated group(n =30). The control group was received conventinal theray,but the treated group re-ceived combinedly atomized inhalation on basis of conventional therapy. The two groups were treated in five-seven days, and were recorded the changes of clinical symptom, physicak sign, arterial blood gas analysis and the related side effect (for example, liver and renal function, blood sugar, etc). Results There are significant difference be-twcen the two groups in clinical effect (P < 0.05). Conclusion Ambroxol, budesonida and terbutaline combinedly atomized inhalation in the treatment of old patients with acute exacerbation of COPD was effective, little side effect and very safe.